Header photograph from the Agios case study

Case Study

eClinical Solutions Agios Case Study

Business Challenges

Clinical data is not only driven by complex protocols and medicine, but it also stems from multiple sources (Labs, EDC, CTMS, wearables, among others). Agios needed a way to collect, compare, and extract meaning from their clinical data.

“The question is how do we utilize technology advantages to manage our clinical data more efficiently?”

Bob O’Connor, Associate Director, Clinical Data Systems, Agios Pharmaceuticals

Agios required a system that would streamline and centralize data acquisition, one that would allow them not only to intake, but to output data for review and analysis. They also wanted a platform that possessed the ability to map that data in a standard structure, SDTM, and enabled the review of data-sets with user friendly visualization. Their ultimate goal was to implement a data hub that would allow them to analyze their data in-house, saving both time and money.

Selecting and evaluating a Clinical Data Intelligence Platform

Agios employed a cross-functional team of members from IT, clinical operations, safety, data management, and biostats. To evaluate the various providers, they created a list of testing criteria that they used like a report card. While the cross-functional team tested the product, a quality team audited the vendor for proper practices.

The first product that Agios piloted took the team four months to fully test. “We learned a lot from that process” said Bob O’Connor, Associate Director, Clinical Data Systems. Though the functionality of the product was adequate, the team agreed that it needed a few enhancements and, overall, the product wasn’t as user friendly as they wanted it to be. The QA team also turned up some unfavorable audit findings. Luckily, the company had better luck piloting a second clinical data intelligence platform: elluminate®.

Use of the elluminate Clinical Data Intelligence Platform

For its second pilot product, Agios used eClinical Solutions’ cloud-based elluminate Clinical Data Intelligence Platform. The elluminate platform allows for end-to-end data management by not only enabling the import of clinical trial data, but by also allowing users to map, visualize, and export that data for submission.

elluminate can ingest data from multiple sources and in almost any format. While the platform retains the data in its original format, it also enables standardization of that data into a powerful relational database engine and groups it into user-defined staging areas. Agios not only made use of elluminate’s data repository capabilities, but also elluminate’s Mapper application. Mapper employs an intuitive drag and drop interface that allows users to produce customized data sets as well as map those sets to SDTM. Once uploaded, both raw and mapped data sets are available for visualization, enabling users to easily review and analyze their data.

Key Practices & Lessons Learned

a) Establish Testing Criteria Know what qualities you wish to evaluate in a product, “Especially if you don’t know what kind of functionality is available in the market at that time, said O’Connor.” Having the criteria and the score card made the ultimate selection of the elluminate Clinical Data Intelligence Platform easy.

b) Involve QA Make sure Quality Assessment is established early in the process. “If we had done this earlier, we might have avoided a dead end that we hit,” said O’Connor, speaking about Agios’ first pilot program. Involving QA in the beginning of its second pilot is part of what allowed O’Connor’s team to swiftly evaluate and implement elluminate.

c) Check Resources “Make sure you have appropriate resources lined up for when you’re doing your testing.” O’Connor advises. Agios had multiple GXP systems going live for other projects, and the Data Systems group was competing for necessary resources.

Results

By implementing data loading, reporting, mapping, and extraction through elluminate, Agios was able to simplify its data flow. As part of the initial rollout, Agios validated elluminate’s data loading module and was able to import data from its Medidata Rave URL as well as from its individual vendors (through the use of Aspera).

To date, Agios has completed SDTM mapping for a number of studies. “I can say with 100% confidence that the system has been proven to generate fully compliant SDTM data sets” said O’Connor.

Moving forward with elluminate.

In its goals for the near future, Agios plans to load all current and historic trial data into elluminate. There are other modules in the platform that Agios would like to employ. “We want to develop SOPs and configure user roles for the Analytics modules,” said O’Connor. Additionally, the company plans to review the Data Central module. “We see Data Central as something that could play a central role in our data review process… That’s something we’re very excited about.”

elluminate Clinical Data Intelligence Platform

  • Is 21 CFR Part 11 Compliant.
  • Is able to configure the System Administration to both user accounts and system metadata.
  • Possesses automated data loading capabilities.
  • Accepts multiple data formats from multiple sources (EDC, FTP, network drives).
  • Is able to identify changes in source data format.
  • Contains an alert system for load failures.
  • Is able to map data sets in SDTM.
  • Is programmable from any source.
  • Includes an efficient mapping interface.
  • Contains SDTM metadata built into the system.
  • Is able to import and export mapping programs for reuse.
  • Contains automated mapping execution.
  • Contains a folder system to store loaded and exported datasets, study documents, etc.
  • Is able to extract data in multiple formats.
  • Is able to automate extracts.
  • Is able to demonstrate data integrity by creating a true copy of data sets.
  • Contains role-based reporting permissions to access reports.
  • Allows for access to canned and programmable reports.
  • Is able to export reports and visualizations in multiple formats.
  • Possesses interactive filtering and drill-down capability.
Continue Reading

Explore the full case study

Complete the form to read the full story and download your copy.

Loading registration form…

Privacy policy